@schaeffer.usc.edu
Home to the Schaeffer Center for Health Policy & Economics and the Schaeffer Fellows in Government Service. Transforming policy through rigorous, independent research and close engagement with public and private sector leaders.
@schaeffer.usc.eduState prescription drug affordability boards were created to address legitimate concerns about drug costs and patient affordability, but they don't use the right measures to assess what patients actually pay, writes USC Schaeffer's William Padula in Health Affairs Forefront.
@schaeffer.usc.eduA ballot proposal in California to tax billionaires is being pitched as a way to offset federal healthcare cuts.
However, USC Schaeffer’s Glenn Melnick tells @kffhealthnews.org that the measure’s ambiguous language could allow lawmakers to use the money for other purposes.
@schaeffer.usc.eduNew treatments that can slow #Alzheimers progression could provide significant value across society, with even greater benefits when treatment starts earlier, according to new USC Schaeffer research.
@schaeffer.usc.eduDementia's economic impact is estimated to hit $818B this year and continue growing. A new interactive tool from USC Schaeffer shows how dementia and new interventions may shape health and economic outcomes in the U.S. over the next 25 years.
@schaeffer.usc.eduER visits among foreign-born patients dropped sharply at L.A. hospitals as immigration enforcement intensified last year, new USC Schaeffer research finds. When foreign-born patients did seek care, they were more likely to be hospitalized.
@schaeffer.usc.eduThe collapse of community is a threat to democracy. Young people didn’t create this problem, but they have power to fix it, former UK Prime Minister Gordon Brown of #USCSchaeffer and Robert Putnam told an audience at the @usc.edu Capital Campus in Washington, DC.
@schaeffer.usc.eduPostpartum GLP-1 use has increased sharply in the US, finds new USC Schaeffer research in @jama.com.
Among commercially insured patients, nearly 1 in 6 new mothers with type 2 diabetes were prescribed a GLP-1 last year, while prescriptions have risen fastest for obesity and overweight.
@schaeffer.usc.eduStates have already allocated billions of dollars from major opioid settlements. The largest share of funds, about 40%, is going toward unknown purposes, finds an analysis of publicly reported data led by USC Schaeffer's Rosalie Liccardo Pacula.
@schaeffer.usc.eduMore than 1 in 5 older adults are taking potentially risky combinations of prescription drugs, according to new research from USC Schaeffer's Dima Qato.
@schaeffer.usc.eduA proposal to tie Medicare physician pay increases to inflation represents a retreat from using sweeping financial incentives to influence how doctors provide care, USC Schaeffer’s Paul Ginsburg told @statnews.com.
@cidrap.bsky.socialReposted by @schaeffer.usc.eduMost older US adults would be interested in a dementia vaccine, survey finds
Researchers asked about a hypothetical vaccine that could cut the risk of dementia in half.
Read more: https://bit.ly/4y9IYDl
📷: CDC
@schaeffer.usc.eduAs policymakers weigh changes to the No Surprises Act’s overburdened arbitration process, USC Schaeffer's Erin Duffy writes that longstanding commercial arbitration and litigation systems offer important lessons for reform.
@schaeffer.usc.eduOlder Americans appear ready to embrace a vaccine that would help prevent dementia. New USC Schaeffer research finds nearly 3 in 4 older adults would be interested in receiving a vaccine that could cut the risk of dementia in half.
@schaeffer.usc.eduNew FDA-approved blood tests can detect signs of #Alzheimers before symptoms appear, creating a critical opportunity for early intervention. Congress should pass bipartisan legislation allowing Medicare coverage, USC Schaeffer's Joe Grogan writes. www.realclearhealth.com/articles/202...
@schaeffer.usc.eduA bill before the House Ways and Means Committee would undermine MedPAC's ability to conduct independent analysis, warned USC Schaeffer Sr. Scholar Paul GInsburg.
@schaeffer.usc.eduPeople who stopped using GLP-1s reported lower trust in pharmaceutical companies than current users and those who never used the treatments, a new USC Schaeffer survey found.
@schaeffer.usc.eduWhether people vote is partly predicted by what they think friends and family will do, new USC Schaeffer research shows.
@schaeffer.usc.eduThe first prescription for sleep medications may play an important role in shaping long-term use. Patients initially prescribed drugs like Ambien for longer durations were more likely to still be using them years later, new USC Schaeffer research finds.
@schaeffer.usc.eduAs the new school year begins, data from the Understanding America Study at USC Schaeffer points to critical gaps between how parents and their teens perceive teens' well-being.
@schaeffer.usc.eduMedicare's GLP-1 Bridge Program is off to a fast start. USC Schaeffer Scholar Jeremy Shane tells @npr.org the program's early success offers an opportunity to think more broadly about how to link medicine prices to value.
